Barry Hyman
Barry Hyman
benefit both companies deals dollars eventually good help helps high marketing merger sector strike terms toward
I think, ... that Pfizer is going to benefit from their merger with Warner-Lambert. I think that makes a very good deal. But most pharmaceutical companies do eventually strike deals with biotech companies in terms of marketing their product. And the genomic companies don't have a lot of cash. They have a lot of high valuations, but they don't have a lot of dollars to spend. So, they usually look toward the pharmaceutical sector to help them out, which usually helps both sectors.
began feeling secure walk week
I think you walk away this week feeling much more secure than you began the week.
acted board federal interest left lower open please properly reserve window
I think the Federal Reserve Board acted properly and left the window open for lower interest rates, which will please the market.
encouraged overly
I was encouraged by today, but not overly so. We need to see a lot more than one day.
emphasis fed key meeting next rate seeing slowing succession
I think we really have to get to the next Fed meeting before anything significant happens. We have to see the emphasis on a slowing economy, and that's key to seeing that there won't be an open-ended succession of rate hikes.
maintain market percentage point quarter whether wire
I think we're going to go down to the wire whether or not it's a half-percentage point (increase). If you want to maintain market stability, a quarter percentage point could keep the market at bay.
accumulate aware easier fed great investor late looking next problems rally small start stock summer tech technology three trading vigorous weak worried
I think it's too late to be worried about where your tech stock is going to go from here. There are some opportunities out there and we are aware of the short-term problems in the marketplace with the Fed being aggressive. So, we're not looking for a very vigorous rally over the next one to three months. There will be trading rallies. But the investor, the small investor, the intermediate-to-long-term investor should use the summer time, which is seasonally weak for technology stocks, to start to accumulate an easier way into some of these great companies,
belief cuts interest medicine psychology rate reaction though week
I think the week was excellent. The Fed, even though the reaction was delayed, reinvigorated the psychology of the market. It's reinforcing the belief that these interest rate cuts will be the medicine for the economy.
future looking market
It is a market looking at the future.
absence apathy cruel days earnings matter reality
I think there's apathy in the market. The cruel reality is that earnings do matter and, in the absence of any new catalyst, you're going to get days like this.
bargain coming good hunting
I think there was some bargain hunting coming in on the back of good news.
confusion depends earnings issue
I think there's enough in the cyclicality issue that it's going to be more of a traders' market, ... I think there's enough confusion out there that so much depends on the third-quarter earnings that we actually do see.
ahead beyond economy half help market near next strength surprising upside
I think there's still more upside ahead into next week, and as we look at the market beyond near term, I think the surprising strength in the economy is going to help us in the first half of 2006.
concern economy expect fed meetings rally seem slightly talk
I think there's a concern about the economy so I think you'll see conciliatory talk (from Fed governors). We seem to rally into Fed meetings so I would expect a slightly upward bias.